Literature DB >> 7664111

Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus.

A Wlodawer1, A Gustchina, L Reshetnikova, J Lubkowski, A Zdanov, K Y Hui, E L Angleton, W G Farmerie, M M Goodenow, D Bhatt.   

Abstract

The crystal structure of a recombinant form of the proteinase encoded by the feline immunodeficiency virus (FIV PR) has been solved at 2 A resolution and refined to an R-factor of 0.148. The refined structure includes a peptidomimetic, statine-based inhibitor, LP-149, which is an even more potent inhibitor of HIV PR. Kinetic parameters were obtained for the cleavage of five substrates by FIV PR, and inhibition constants were measured for four inhibitors. The structure of FIV PR resembles other related retroviral enzymes although few inhibitors of HIV PR are capable of inhibiting FIV PR. The structure of FIV PR will enhance our knowledge of this class of enzymes, and will direct testing of new proteinase inhibitors in a feline animal model.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664111     DOI: 10.1038/nsb0695-480

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  27 in total

1.  Viral evolution in response to the broad-based retroviral protease inhibitor TL-3.

Authors:  B Bühler; Y C Lin; G Morris; A J Olson; C H Wong; D D Richman; J H Elder; B E Torbett
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV protease.

Authors:  Ying Chuan Lin; Alexander L Perryman; Arthur J Olson; Bruce E Torbett; John H Elder; C David Stout
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-05-12

3.  Structural and biochemical characterization of the inhibitor complexes of xenotropic murine leukemia virus-related virus protease.

Authors:  Mi Li; Alla Gustchina; Krisztina Matúz; Jozsef Tözsér; Sirilak Namwong; Nathan E Goldfarb; Ben M Dunn; Alexander Wlodawer
Journal:  FEBS J       Date:  2011-10-10       Impact factor: 5.542

4.  Structure of RC1339/APRc from Rickettsia conorii, a retropepsin-like aspartic protease.

Authors:  Mi Li; Alla Gustchina; Rui Cruz; Marisa Simões; Pedro Curto; Juan Martinez; Carlos Faro; Isaura Simões; Alexander Wlodawer
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2015-09-30

5.  Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.

Authors:  Ying-Chuan Lin; Ashraf Brik; Aymeric de Parseval; Karen Tam; Bruce E Torbett; Chi-Huey Wong; John H Elder
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

6.  Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease.

Authors:  Y C Lin; Z Beck; T Lee; V D Le; G M Morris; A J Olson; C H Wong; J H Elder
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Molecular analysis of the feline immunodeficiency virus protease: generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases.

Authors:  G S Laco; M C Fitzgerald; G M Morris; A J Olson; S B Kent; J H Elder
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

8.  Feline immunodeficiency virus reverse transcriptase: expression, functional characterization, and reconstitution of the 66- and 51-kilodalton subunits.

Authors:  M Amacker; M Hottiger; U Hübscher
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Toward a universal inhibitor of retroviral proteases: comparative analysis of the interactions of LP-130 complexed with proteases from HIV-1, FIV, and EIAV.

Authors:  J Kervinen; J Lubkowski; A Zdanov; D Bhatt; B M Dunn; K Y Hui; D J Powell; J Kay; A Wlodawer; A Gustchina
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

Review 10.  Molecular mechanisms of FIV infection.

Authors:  John H Elder; Magnus Sundstrom; Sohela de Rozieres; Aymeric de Parseval; Chris K Grant; Ying-Chuan Lin
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.